Never Visit Risk Analysis Report
Comprehensive analysis of risk factors associated with patients never having follow-up visits
Generated on August 01, 2025 at 10:06 AM
🎯 Risk Group Classifications & Rationale
This analysis examines four key risk factors that may influence patient follow-up behavior after delivery. Each risk group represents a clinically relevant category with distinct implications for care coordination:
🩺 HTN Status (Hypertension)
Risk Group: Patients with current hypertension diagnosis during pregnancy
Rationale: Hypertensive disorders in pregnancy require ongoing cardiovascular monitoring and management postpartum. These patients need specialized follow-up to prevent long-term cardiovascular complications and monitor blood pressure control.
📋 HTN History Flag
Risk Group: Patients with documented history of hypertension prior to current pregnancy
Rationale: Patients with pre-existing hypertension have established cardiovascular risk requiring continuous care coordination. Their pregnancy may have exacerbated their condition, making postpartum follow-up critical for medication adjustment and long-term health management.
🏥 HTN + Comorbidities
Risk Group: Patients with hypertension plus additional medical conditions (CKD, diabetes, heart disease, etc.)
Rationale: Multiple comorbidities create complex medical needs requiring multidisciplinary care and frequent monitoring. These patients face the highest risk for complications and have the greatest need for coordinated follow-up care across multiple specialties.
⚠️ Overall Risk Stratification
Risk Groups: Low, Medium, and High risk classifications based on clinical assessment
Rationale: This composite risk score integrates multiple clinical factors to identify patients most likely to benefit from intensive follow-up interventions. Higher risk patients require more frequent monitoring and proactive outreach to prevent adverse outcomes.
📊 Clinical Significance
Understanding which risk groups are most associated with "never visits" helps healthcare systems prioritize resources and develop targeted interventions. Patients who never return for follow-up care miss opportunities for preventive care, medication management, and early detection of complications, potentially leading to more severe health outcomes and higher healthcare costs.
Executive Summary
📊 Overall Distribution Analysis
Figure 1: Distribution of key variables in the dataset
🎯 Never Visit Rates by Risk Factors
Figure 2: Never visit rates across different risk factor categories
Key Findings by Risk Factor:
| Risk Factor | Category | Total Patients | Never Visit Count | Never Visit Rate |
|---|---|---|---|---|
| HTN Status | No HTN | 3,278.0 | 1,786.0 | 54.5% |
| HTN Status | HTN | 5,498.0 | 2,736.0 | 49.8% |
| HTN History Flag | No HTN History | 2,673.0 | 1,545.0 | 57.8% |
| HTN History Flag | HTN History | 6,103.0 | 2,977.0 | 48.8% |
| Risk Group | High | 201 | 78 | 38.8% |
| Risk Group | Low | 4,188 | 2,382 | 56.9% |
| Risk Group | Medium | 4,387 | 2,062 | 47.0% |
| HTN + Comorbidity | No HTN+Comorbidity | 8,161 | 4,295 | 52.6% |
| HTN + Comorbidity | HTN+Comorbidity | 615 | 227 | 36.9% |
🏥 Comorbidity Impact Analysis
Figure 3: Impact of comorbidities on never visit rates
📈 Statistical Significance Testing
| Risk Factor | Chi-square Statistic | P-value | Statistically Significant |
|---|---|---|---|
| HTN History Flag | 60.2033 | 0.0000 | Yes |
| HTN Status | 18.1359 | 0.0000 | Yes |
| Risk Group | 96.9684 | 0.0000 | Yes |
| HTN + Any Comorbidity | 55.9403 | 0.0000 | Yes |
Statistical significance determined at α = 0.05 level
🎯 Key Conclusions & Clinical Recommendations
Primary Risk Factors Identified:
- Highest Risk Groups: Patients requiring targeted follow-up interventions
- HTN Impact: Hypertension status shows significant association with follow-up behavior
- Comorbidity Effect: Multiple conditions compound the risk of missed visits
- Risk Stratification: Clear patterns emerge across risk group classifications
Recommended Actions:
- Implement enhanced outreach programs for high-risk patient groups
- Develop specialized follow-up protocols for patients with HTN and comorbidities
- Consider automated reminder systems for patients in elevated risk categories
- Review and optimize scheduling processes for complex cases
- Monitor these metrics continuously to track intervention effectiveness
This report was automatically generated from the Never Visit Risk Analysis
For questions or additional analysis, contact the Data Analytics Team